Skip to main content
Log in

Astrocytic pathology of methionine sulfoximine-induced encephalopathy

  • Regular Papers
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Summary

To investigate the roles imposed on astrocytes for glutamate metabolism, a specific inhibitor of glutamine synthetase (GS), methionine sulfoximine (MSO), was repeatedly administered to rats and histopathological changes were correlated with glycogen accumulation and the immunocytochemistry of GS and glial fibrillary acidic protein (GFAP). Prolonged MSO-loading (every 12 h up to three times, 100–150 mg/kg body weight) brought about the appearance of astrocytes with swollen, watery nuclei reminiscent of Alzheimer II glia chiefly in the neocortex, hippocampus and lateral thalamus after 24 h. Concomitantly, profound accumulation of glycogen ensued in the superficial three layers of the neocortex, hippocampus and pyriform cortex. GS immunoreactivity appeared enhanced in the cortex, hippocampus and lateral thalamus with parallel increase in GFAP immunoreactivity after prolonged treatment. Oligodendrocytes in the diencephalon and brain stem also normally contained GS immunoreactivity. Some animals developed necrotic lesions in the dorsolateral neocortex. The area of glycogen accumulation coincided with the known distribution ofN-methyld-aspartate (NMDA) glutamate receptors and, thus, GS may play important roles in NMDA receptor-mediated glutamate metabolism. The Alzheimer II type changes, however, did not correlate with NMDA-receptor distribution. These results indicate certain regionalizations in the roles of astrocytes and oligodendrocytes in glutamate and ammonia metabolisms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bruton CJ, Corsellis JAN, Russel A (1970) Hereditary hyperammonemia. Brain 93:423–434

    Google Scholar 

  2. Cavanagh JB, Kyu MH (1971) Type II Alzheimer change experimentally produced in astrocytes in the rat. J Neurol Sci 12:63–75

    Google Scholar 

  3. Chaney AL, Marbach EP (1962) Modified reagents for determination of urea and ammonia. Clin Chem 8:130–132

    Google Scholar 

  4. Cole M, Rutherford RB, Smith FO (1972) Experimental ammonia encephalopathy in the primate. Arch Neurol 26:130–136

    Google Scholar 

  5. Cotman CW, Monaghan DT, Ottersen OP, Storm-Mathisen J (1987) Anatomical organization of excitatory amino acid receptors and their pathways. Trends Neurosci 10:273–280

    Google Scholar 

  6. DeRobertis E, Sellinger OZ, Arnaiz RDG, Alberici M, Zieher LM (1967) Nerve endings in methionine sulphoximine convulsant rats. A neurochemical and ultrastructural study. J Neurochem 14:81–89

    Google Scholar 

  7. Faggs GE, Foster AC (1983) Amino acid neurotransmitters and their pathways in the mammalian central nervous system. Neuroscience 9:701–719

    Google Scholar 

  8. Folbergrová J (1973) Glycogen and glycogen phosphorylase in the cerebral cortex of mice under the influence of methionine sulfoximine. J Neurochem 20:547–557

    Google Scholar 

  9. Fonnum F, Sorenssen DM (1981) Localization of glutamate neurons. In: Roberts PJ, Storm-Mathisen J, Johnston AR (eds) Glutamate transmitter in the central nervous system. Wiley & Sons, Chichester, pp 205–222

    Google Scholar 

  10. Gregorios JB, Mozes LW, Norenberg MD (1985) Morphologic effects of ammonia on primary astrocyte cultures. I. Light microscopic studies. J Neuropathol Exp Neurol 44:397–403

    Google Scholar 

  11. Gutierrez JA, Norenberg MD (1975) Alzheimer II astrocytosis following methionine sulfoximine. Arch Neurol 32:123–126

    Google Scholar 

  12. Gutierrez JA, Norenberg MD (1977) Ultrastructural study of methionine sulfoximine-induced Alzheimer type II astrocytosis. Am J Pathol 86:285–300

    Google Scholar 

  13. Hsu SM, Raine L, Franger H (1981) Use of avidin-biotinperoxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 29:577–580

    Google Scholar 

  14. Iizuka H, Yamamoto H, Iwasaki Y, Yamamoto T, Konno H (1987) Evolution of tissue damage in compressive spinal cord injury in rats. J Neurosurg 66:595–603

    Google Scholar 

  15. Isacson O, Fischer W, Wictorin K, Dawbarn D (1987) Astroglial response in the excitotoxically lesioned neostriatum and its projection areas in the rat. Neuroscience 20:1043–1056

    Google Scholar 

  16. Jessen KR, Mirsky R (1983) Astrocyte-like glia in the peripheral nervous system: An immunohistochemical study of enteric glia. J Neurosci 3:2206–2218

    Google Scholar 

  17. Juurlink BH (1982) Glutamine synthetase and glutamyltransferase activities in the mouse astrocyte in vitro. Neurochem Res 7:905–910

    Google Scholar 

  18. Kimura T, Budka H (1986) Glial fibrillary acidic protein and S-100 protein in human hepatic encephalopathy: immunocytochemical demonstration of dissociation of two glia-associated proteins. Acta Neuropathol (Berl) 70:17–21

    Google Scholar 

  19. Kretzschmar HA, DeArmond SJ, Forno LS (1985) Measurement of GFAP in hepatic encephalopathy by ELISA and transblots. J Neuropathol Exp Neurol 44:459–471

    Google Scholar 

  20. Lin S, Raabe W (1985) Ammonia intoxication: effects on cerebral cortex and spinal cord. J Neurochem 44:1252–1258

    Google Scholar 

  21. Ljunggren B, Schutz H, Siesjö BK (1974) Changes in energy state and acid-base parameters of the rat brain during complete compression ischemia. Brain Res 73:277–289

    Google Scholar 

  22. Martinez-Hernandez A, Bell KP, Norenberg MD (1977) Glutamine synthetase: glial localization in brain. Science 195:1356–1358

    Google Scholar 

  23. Moroni F, Lombardi G, Moneti G, Cortesini C (1983) The release and neosynthesis of glutamic acid are increased in experimental models of hepatic encephalopathy. J Neurochem 40:850–854

    Google Scholar 

  24. Morris JE, Moscdna AA (1970) Induction of glutamine synthetase in embryonic retina: its dependence on cell interactions. Science 167:1736–1738

    Google Scholar 

  25. Norenberg MD (1979) The distribution of glutamine synthetase in the rat central nervous system. J Histochem Cytochem 27:756–762

    Google Scholar 

  26. Norenberg MD, Martinez-Hernandez A (1979) Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res 161:303–310

    Google Scholar 

  27. Norenberg MD, Lapham LW, Nichols FA, May AG (1974) An experimental model for the study of hepatic encephalopathy. Arch Neurol 31:106–109

    Google Scholar 

  28. Oda M, Ikeda K, Yamamoto T (1983) Immunohistochemistry of glutamine synthetase of the mouse and human brain. A preliminary study on pathogenesis of hepatic gliopathy (in Japanese with English summary). Neuropathology (Tokyo) 4:19–30

    Google Scholar 

  29. Phelps CH (1975) An ultrastructural study of methionine sulphoximine-induced glycogen accumulation in astrocytes of the mouse cerebral cortex. J Neurocytol 4:479–490

    Google Scholar 

  30. Raabe W, Gumnit RJ (1975) Disinhibition in cat motor cortex by ammonia. J Neurophysiol 38:347–355

    Google Scholar 

  31. Raff MC, Miller RH, Noble M (1983) A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature 303:390–396

    Google Scholar 

  32. Rothman SM, Olney JW (1986) Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 19:105–111

    Google Scholar 

  33. Rothman SM, Olney JW (1987) Excitotoxicity and the NMDA receptor. Trends Neurosci 10:299–302

    Google Scholar 

  34. Van den Berg CJ (1970) Glutamate and glutamine. In: Lajtha A (ed) Handbook of neurochemistry. Plenum, New York, p 355

    Google Scholar 

  35. Walker CO, Schenker S (1985) Pathogenesis of hepatic encephalopathy with special reference to the role of ammonia. Am J Clin Nutr 44:459–471

    Google Scholar 

  36. Warren KS, Schenker S (1964) Effect of an inhibitor of glutamine synthesis (methionine sulfoximine) on ammonia toxicity and metabolism. J Lab Clin Med 64:442–449

    Google Scholar 

  37. Warringa RAJ, van Berlo MF, Klein W, Lopes-Cardozo M (1988) Cellular localization of glutamine synthetase and lactic dehydrogenase in oligodendrocyte-enriched cultures from rat brain. J Neurochem 50:1461–1468

    Google Scholar 

  38. Yamamoto H, Konno H, Yamamoto T, Ito K, Mizugaki M, Iwasaki Y (1987) Glutamine synthetase of the human brain: purification and characterization. J Neurochem 28:23–30

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by the grants-in-aid from the Ministry of Education, Science and Culture (Projects 63480214 and 63870063 to T. Yamamoto), and from the Ministry of Health (for Neurodegenerative disorders to T. Yamamoto), Japan

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamamoto, T., Iwasaki, Y., Sato, Y. et al. Astrocytic pathology of methionine sulfoximine-induced encephalopathy. Acta Neuropathol 77, 357–368 (1989). https://doi.org/10.1007/BF00687370

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00687370

Key words

Navigation